Filtered By:
Vaccination: Cancer Vaccines

This page shows you your search results in order of date. This is page number 17.

Order by Relevance | Date

Total 243 results found since Jan 2013.

RNA: The new revolution in nucleic acid vaccines.
Abstract Nucleic acid vaccines have the potential to address issues of safety and effectiveness sometimes associated with vaccines based on live attenuated viruses and recombinant viral vectors. In addition, methods to manufacture nucleic acid vaccines are suitable as generic platforms and for rapid response, both of which will be very important for addressing newly emerging pathogens in a timely fashion. Plasmid DNA is the more widely studied form of nucleic acid vaccine and proof of principle in humans has been demonstrated, although no licensed human products have yet emerged. The RNA vaccine approach, based on...
Source: Seminars in Immunology - June 1, 2013 Category: Allergy & Immunology Authors: Geall AJ, Mandl CW, Ulmer JB Tags: Semin Immunol Source Type: research

La Jolla Institute Identifies Molecular SwitchEnabling Immune Cells To Better Fight Disease
Finding on Killer Cells Opens New Avenue for Combating AIDS, Cancer and other Diseases A research team led by the La Jolla Institute for Allergy & Immunology has discovered the mechanism that enables CD4 helper T cells to assume the more aggressive role of killer T cells in mounting an immune attack against viruses, cancerous tumors and other damaged or infected cells...
Source: Health News from Medical News Today - January 24, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

Finding On Killer Cells Opens New Avenue For Combating AIDS, Cancer And Other Diseases
A research team led by the La Jolla Institute for Allergy & Immunology has discovered the mechanism that enables CD4 helper T cells to assume the more aggressive role of killer T cells in mounting an immune attack against viruses, cancerous tumors and other damaged or infected cells. The finding, made in collaboration with researchers from the RIKEN Institute in Japan, could enable the development of more potent drugs for AIDS, cancer and many other diseases based on using this mechanism to trigger larger armies of killer T cells against infected or damaged cells...
Source: Health News from Medical News Today - January 22, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news